Abstract

Alzheimer’s disease (AD) is a chronic neurodegenerative disease and the most common form of dementia in older adults. Treatment of AD symptoms is very challenging and expensive. Appropriate diet as well as mental and physical activity may delay or reduce the occurrence of AD. It is unknown whether environmental factors offer potentially protective effects against the development of AD. We explored the possible beneficial effects of greenspace (trees and herbaceous cover) on the rate of AD in the mid-Atlantic US. Data for initial AD medical claims during 2011–2013 were obtained from Medicare records for 2999 ZIP codes. The percentages of land cover classes in each ZIP code were calculated based on high-resolution land cover imagery. Associations between AD and greenspace, blue space (water), and other variables were examined using zero-inflated Poisson models. The rate of AD was negatively associated with greenspace (for a greenspace increase of 10%, risk ratio (RR) = 0.91, 95% confidence interval (CI): 0.89–0.94), and blue space (for a water area increase of 10%, RR = 0.85, 95% CI: 0.81–0.89). The inverse relationships between greenspace and the risk of AD held across season, gender, and race. The rate of AD was positively associated with the concentration of fine particulate matter (PM2.5) (RR = 1.03, 95% CI: 1.02–1.05 for an increase in PM2.5 of 1 μg/m3). Our results suggest that greenspace may have protective effects for AD, although potential mechanisms are unclear and require further investigation.

Highlights

  • Our results suggest that greenspace may have protective effects for Alzheimer’s disease (AD), potential mechanisms are unclear and require further investigation

  • The results showed that AD rate was positively associated with PM2.5 (for a 1 μg/m3 increase in PM2.5 concentration, RR = 1.03, 95% confidence interval (CI) = 1.02–1.05)

  • We observed a lower AD rate associated with increasing greenspace and water area in the mid-Atlantic US

Read more

Summary

Introduction

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Alzheimer’s disease (AD) is a progressive neurodegenerative disease that gradually impairs memory and thinking skills, leading to the loss of independence and the inability to perform the basic activities of daily life [1]. The overproduction of the amyloid-β (Aβ) peptides and hyperphosphorylation of the Tau protein and its subsequent deposition are hypothesized as two major mechanisms to develop AD [2,3]. While its mechanism is unknown, it is the most common cause of dementia in older adults and is ranked as the sixth leading cause of mortality in the US. More than 5 million people may currently have

Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call